These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1473850)

  • 1. Adverse reactions to gentamycin in patients with ear, nose or throat infections.
    Singhal S; Sharma SC; Singhal KC
    Indian J Physiol Pharmacol; 1992 Jul; 36(3):189-92. PubMed ID: 1473850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Topical ototoxicity: review over a 6-year period].
    Abelló P; Viñas JB; Vega J
    Acta Otorrinolaringol Esp; 1998; 49(5):353-6. PubMed ID: 9717322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of ear, nose and throat infections with clofoctol.
    Ghilardi PL; Casani A
    Drugs Exp Clin Res; 1985; 11(11):815-8. PubMed ID: 3915468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical ciprofloxacin versus topical gentamicin for chronic otitis media.
    Nawasreh O; Fraihat A
    East Mediterr Health J; 2001; 7(1-2):26-30. PubMed ID: 12596948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inner ear and facial nerve complications of acute otitis media with focus on bacteriology and virology.
    Hydén D; Akerlind B; Peebo M
    Acta Otolaryngol; 2006 May; 126(5):460-6. PubMed ID: 16698694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experience with Gentamycin in E. N. T. with particular consideration of its potential side effects].
    Federspil P
    Munch Med Wochenschr; 1968 Nov; 110(46):2717-22. PubMed ID: 5755577
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicomicrobiologic evaluation of active tubotympanic type chronic suppurative otitis media.
    Khanna V; Chander J; Nagarkar NM; Dass A
    J Otolaryngol; 2000 Jun; 29(3):148-53. PubMed ID: 10883827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of the safety of isepamicin in adults.
    Blum D
    J Chemother; 1995 Jun; 7 Suppl 2():87-93. PubMed ID: 8622116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microbiological and auditory analysis before and after topical treatment of chronic suppurative otitis media without cholesteatoma].
    Lorente L; Quesada P; García M; Serra J; López de Argumedo I; Quesada JL; Perelló E
    An Otorrinolaringol Ibero Am; 1997; 24(6):581-92. PubMed ID: 9549149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of Triethanolamine (CAS No. 102-71-6) in F344 Rats and B6C3F1 Mice (Dermal Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Nov; 449():1-298. PubMed ID: 12594526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical treatment for otorrhea: issues and controversies.
    Bance M; Rutka JA
    J Otolaryngol; 2005 Aug; 34 Suppl 2():S52-5. PubMed ID: 16076416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of Promethazine Hydrochloride (CAS No. 58-33-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Dec; 425():1-272. PubMed ID: 12616286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of 1,2-Dihydro-2,2,4-Trimethylquinoline (CAS No. 147-47-7) in F344/N Rats and B6C3F1 Mice (Dermal Studies) and the Dermal Initiation/Promotion Study in Female Sencar Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Feb; 456():1-312. PubMed ID: 12587020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Injectable lincocin in the treatment of ORL infections].
    Muler H
    Ann Otolaryngol Chir Cervicofac; 1976 Jun; 93(6):443-6. PubMed ID: 984650
    [No Abstract]   [Full Text] [Related]  

  • 16. [Usefulness of fenspiride in the treatment of acute otitis media in children].
    Zielnik-Jurkiewicz B; Jurkiewicz D
    Pol Merkur Lekarski; 2005 Jun; 18(108):624-8. PubMed ID: 16124370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ototoxicity of micronomicin sulfate--audiometric assessment].
    Hohzawa K; Shibuya M; Yuasa R
    Jpn J Antibiot; 1983 Oct; 36(10):2921-4. PubMed ID: 6674525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of gentamycin in renal failure (our experience in 31 patients)].
    Rentero R; Vidaur F; Naranjo P; Fereres J
    Rev Clin Esp; 1974 Mar; 132(5):451-4. PubMed ID: 4831276
    [No Abstract]   [Full Text] [Related]  

  • 19. [The question of ototoxicity of gentamycin therapy in children].
    Innitzer J; Moser G; Rosenkranz A
    Adv Clin Pharmacol; 1978; 15():149-55. PubMed ID: 676874
    [No Abstract]   [Full Text] [Related]  

  • 20. Contact sensitivity to gentamicin-hydrocortisone ear drops.
    Robinson PM
    J Laryngol Otol; 1988 Jul; 102(7):577-8. PubMed ID: 2970514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.